Skip to main content
. 2021 Jul 3;11(7):980. doi: 10.3390/biom11070980

Table 2.

Changes of exosomal proteins in AD.

Category Level Exosomal Proteins
Aβ targeted Increase Aβ42, APP, sAPPβ, BACE-1
Decrease Aβ42, APP
No change Aβ42, APP, sAPPα, sAPPβ, BACE-1, Aβ42/p-T181-tau, γ-secretase
Tau targeted Increase t-tau, p-T181-tau, p-T231-tau, p-S202-tau, p-S396-tau, p-tau/t-tau, p-T181-tau/t-tau,-tau/Aβ42
Decrease t-tau
No change t-tau, p-T181-tau, p-S396-tau, p-T181-tau/t-tau, t-tau/Aβ42, N-224 tau, N-123 tau, MR tau, FL tau
Synaptic protein Decrease NRGN, synaptophysin, synaptotagmin, synaptopodin, SNAP-25, AMPA4 receptor, NPTX2, NLGN1, NRXN2, p-S9-synapsin 1, synapsin 1, MOG
Autolysosomal Increase cathepsin D, LAMP-1
No change cathepsin D, LAMP-1
Growth/trophic Increase GDNF
Decrease GDNF, FGF-2, FGF-13, HGF, IGF-1
Brain insulin resistance Increase p-Y-IRS-1, p-S312-IRS-1, p-S312-IRS-1/p-Y-IRS-1
Decrease p-Y-IRS-1
No change t-IRS-1, p-Y-IRS-1, p-S312-IRS-1, p-S312-IRS-1/p-Y-IRS-1
Inflammatory related Increase MMP-9, TSPO
No change IL-6
Molecular chaperone Increase ubiquitinylated protein
Decrease HSP70
No change HSP70, ubiquitinylated protein
Transcriptional repressor Decrease REST
Cell type marker Increase GFAP, NF-Lch, NS-enolase
Decrease GFAP, GluSyn
No change GluSyn, NF-Lch, NS-enolase
Exosome marker Decrease CD81
No change CD81, TSG101
Other Increase GM1
Decrease GAP43, Septin-8
No change Septin-8